Alexis Ji Email and Phone Number
Alexis Ji work email
- Valid
- Valid
Alexis Ji personal email
Alexis Ji is a Founding Partner at Primer Ventures | ex-Illumina Ventures, WuXi, ARCH at Primer Ventures. She possess expertise in genomics, bioinformatics, biotechnology, life sciences, drug discovery and 22 more skills. She is proficient in English and Mandarin. Colleagues describe her as "I had the pleasure of working with Yongmei while she was at Roche, and rapidly appreciated that she was an extremely gifted bioinformatician. She is exceedingly hard working, and yet remains innovative in her approaches to complex problems. I am honored to provide a recommendation for her, as I expect that she will be an extraordinary asset for any employer." and "Yongmei joined the in silico sciences group and was in the matter of a few weeks fully functioning in her role supporting and partnering with project team scientists in virology. This is a testament to a variety of her outstanding qualities, including deep bioinformatics domain knowledge, direct communication skills, strong work ethic, adept analytic skills, and easy-going demeanor. She has been a delight to work with and she has quickly become a valuable and well-liked member of the team. Yongmei is someone who is able to work independently yet knows when to seek more information to solve problems given to her. She engages researchers and colleagues in productive dialog and offers her opinions in a clear, succint, and respectful manner. She is very organized, conscientious and detailed-oriented, yet is also able to see the larger picture. This positions her well to lead projects and work with both technical and scientific personnel, as she has been doing already. In short, she is able to run with problems and projects with little supervision, with outstanding, timely delivery which makes her highly valued. I highly recommend Yongmei and believe she would be a great asset to any organization."
-
Founding PartnerPrimer Ventures Jan 2023 - PresentSan Francisco Bay AreaPrimer Ventures is a venture capital firm investing in early-stage companies in the fields of life science tools and innovative therapeutics. It provides early capital to empower visionary entrepreneurs in translating cutting-edge science and technologies into transformative products or therapies. -
Byers Center For Biodesign Spectrum Oversight Committee MemberStanford University Feb 2022 - PresentStanford, California, United States -
Spark Translational Science Program AdvisorStanford University Mar 2017 - PresentStanford, California, United States -
Predictives And Diagnostics Accelerator (Spada) Spectrum Program AdvisorStanford University Nov 2016 - Feb 2020Stanford, California, United States -
George Shultz Innovation Fund Advisory Committee MemberUniversity Of Chicago Mar 2021 - PresentChicago, Illinois, United States -
Leap Gap Fund AdvisorWashington University In St. Louis Sep 2019 - PresentSt Louis, Missouri, United States -
Board MemberWalking Fish Therapeutics, Inc. Aug 2021 - Dec 2022Pioneering company developing B-cell technology platforms: to harness B cells’ capability to activate the immune system in the treatment of cancer, and to serve as in vivo protein factories that produce replacement proteins for deficiency diseases, regenerative proteins, and engineered antibodies. -
Board MemberStealth Mode Company May 2021 - Dec 2022Non-viral gene delivery platform
-
Board MemberActym Therapeutics, Inc. Apr 2020 - Dec 2022Cutting-edge immuno-oncology platform enabling microbial-based delivery of multiplexed immunological payloads to the tumor microenvironment after IV dosing -
PartnerIllumina Ventures Jul 2016 - Dec 2022San Francisco Bay AreaEarly-stage life science venture investment, focused on research tools, therapeutics, diagnostics, and wellness.Responsible for all aspects of fund operations, including fundraising, deal sourcing, investment, portfolio management, investor relations and fund administration. -
Board MemberNanocellect Biomedical, Inc. Nov 2017 - Aug 2022Microfluidics-based, viable, sterile, portable, and affordable cell sorters and dispensers, enabling de-centralized cell analysis and isolation for single-cell multi-omics, gene editing, cell line development, and cell and gene therapy applications -
Board ObserverSqz Biotechnologies May 2018 - Oct 2020Next-generation cell therapies with proprietary technologies to "squeeze" antigens into cells, enabling production timelines of under 24 hr, with the potential of generating strong target-specific immune response (activation or tolerance) for the treatment of tumor, infectious or autoimmune diseases
-
Board ObserverTwist Bioscience May 2014 - Oct 2018Leading innovative silicon-based DNA synthesis process, enabling high-throughput, cost-effective, high-fidelity synthesis of genes and oligo pools for the synthetic biology, research and biopharmaceutical industries -
Board ObserverVivace Therapeutics, Inc. Jan 2015 - Jun 2016Oncology-focused small molecule discovery and development company developing first-in-class therapies targeting the Hippo pathway -
PrincipalWuxi Healthcare Ventures Jan 2014 - Jun 2016San Francisco Bay AreaEarly-stage life science venture investment in therapeutics, tools and diagnostics, and digital health.Highly engaged in investment in Twist Bioscience, 23andme, Juno Therapeutics, Unity Biotechnology, Vivace Therapeutics, Ideaya Therapeutics, Medeor Therapeutics, Syros Pharmaceuticals, Impact Therapeutics, among others. -
Venture Investment ConsultantArch Venture Partners Feb 2012 - Jan 2014Greater Chicago AreaEarly-stage life science venture investment in tools/instrumentation, therapeutics, and healthcare.Founding investor member in Twist Bioscience; supported operations of portfolio companies. -
Staff Scientist, Project LeadLife Technologies Aug 2010 - Sep 2011San Francisco Bay AreaMolecular diagnostics in applied market, PCR and Next Generation Sequencing -
Senior Scientist, Project LeadRoche Pharmaceuticals Aug 2009 - Aug 2010San Francisco Bay AreaTranslational research and clinical trial support in virology -
Senior Scientist, Project LeadMerck & Co. Oct 2004 - Jul 2009Greater Seattle AreaDrug discovery, target identification, translational science, genomics research
Alexis Ji Skills
Alexis Ji Education Details
-
Master In Business Administration -
Molecular Genetics
Frequently Asked Questions about Alexis Ji
What company does Alexis Ji work for?
Alexis Ji works for Primer Ventures
What is Alexis Ji's role at the current company?
Alexis Ji's current role is Founding Partner at Primer Ventures | ex-Illumina Ventures, WuXi, ARCH.
What is Alexis Ji's email address?
Alexis Ji's email address is al****@****res.com
What schools did Alexis Ji attend?
Alexis Ji attended The University Of Chicago - Booth School Of Business, Washington University In St. Louis.
What skills is Alexis Ji known for?
Alexis Ji has skills like Genomics, Bioinformatics, Biotechnology, Life Sciences, Drug Discovery, Venture Capital, Due Diligence, Molecular Biology, Dna Sequencing, Data Analysis, Drug Development, Entrepreneurship.
Not the Alexis Ji you were looking for?
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial